ReviewFrontiers in public health2026
Breaking psychedelic boundaries in public health: emerging ideas with ancient roots.
Review in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The modern United States faces significant public health challenges, including a mental health crisis and healthcare systems with numerous shortcomings. At the same time, emerging research on psychedelic substances demonstrates their robust applications for health and well-being, as well as their nuanced risks. While regulators explore how psychedelics can be incorporated into existing healthcare models, patterns of psychedelic use extend beyond clinical settings. These naturalistic or non-clinical applications-for spiritual growth, social bonding, ecological connection, and overall health-have occurred for thousands of years in various cultural contexts. In this critical analysis, we examine historical evidence depicting how psychedelics were utilized in the Americas, before and after European colonization. We highlight the racialized and religious origins of prohibitionist drug policy, as well as U.S. healthcare norms that constrain avenues for mental health, personal choice, and general flourishing. By drawing on interdisciplinary research in clinical mental health, history, anthropology, and medical sociology, we argue for (A.) holistic improvements to narrow mental healthcare models and (B.) an expanded-access posture towards psychedelics that includes non-clinical use scenarios. Our review of existing evidence supports these approaches for improving public mental health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.